Synthetic Biology and Illegal Weapon Development Promises, Promises Brett Edwards.

Slides:



Advertisements
Similar presentations
Do we need a GN of NGOs? Yes! (as far as participation in the GN does not reduce/affect involvement in the GP/DRR) The GN should build on existing networks.
Advertisements

Professor Dave Delpy Chief Executive of Engineering and Physical Sciences Research Council Research Councils UK Impact Champion Competition vs. Collaboration:
When quality meets quantity: the role of qualitative data in framing health inequalities policy Chris Carmona, Catherine Swann and Mike Kelly National.
The Role of Environmental Monitoring in the Green Economy Strategy K Nathan Hill March 2010.
NMP-NCP meeting - Brussels, 27 Jan 2005 Towards FP 7: Preliminary principles and orientations… Nicholas Hartley European Commission DG Research DG Research.
BIOETHICS: THE SUBJECT, PURPOSE AND OBJECTIVES OF THE HEALTH CARE SYSTEM. BIOETHICS OF BIOMEDICAL EXPERIMENTS. INTERNATIONAL DOCUMENTS ON BIOETHICS AND.
M.A. in Homeland Security and Emergency Preparedness (HSEP) L. Douglas Wilder School of Government and Public Affairs, Virginia Commonwealth University.
Human Practices Thrust 4 examines synthetic biology within a frame of human practices, with reciprocal emphasis on ways that economic, political, and cultural.
Awareness and Education About the BTWC Professor Malcolm Dando University of Bradford UK.
Mainstreaming Disaster Risk Management in Iraq
The International Regulation of Biotechnology Lecture No. 19 Further Inf. For further information and video link please click on the right buttons in the.
Addressing Synthetic Biology and Biosecurity
Nanoscale Science and Engineering Center Performance on Societal Objectives Jan Youtie Georgia Institute of Technology American Evaluation Association.
The IGERT Program Preliminary Proposals June 2008 Carol Van Hartesveldt IGERT Program Director IGERT Program Director.
What Do Toxicologists Do?
Regulation of the Life Sciences Lecture No Outline Literature Reviews –Slides Regulating Synthetic Genomics –Slides NSABB Proposals.
Overview of the Lectures in the Education Module Resource Lecture No. 1.
UK Office for Security & Counter Terrorism Future threats and the potential role of the CBRN Action plan in supporting the BTWC Dr Catherine Terry International.
1 Webinar on: Establishing a Fully Integrated National Food Safety System with Strengthened Inspection, Laboratory and Response Capacity Sponsored by Partnership.
Overview of the Child Welfare System International Center for Innovation in Domestic Violence Practice (ICIDVP)
Creating the relationship between good science and informed policy John C. Tracy, Director Idaho Water Resources Research Institute University of Idaho.
Principles for the Oversight of Synthetic Biology- Precautionary Principle 1  “When an activity raises threats of harm to human health or the environment,
Pakistan National Accreditation Council. Biorisk Management.
Synthetic Biology in the Real World: Taking the Big View Learning from Others Preparing for the Inevitable UCSF- SynBerc 1/18/12 Margaret S. Race, Ph.D.
Image 1 – Tomato seedling iStockphoto/Thinkstock, Image 2 – Fermenter iStockphoto/Thinkstock 2011, Image 3 – Wheat Hermerara/Getty Images, Image 4 –DNAConfig.
DUAL USE BIOETHICS AND LIFE SCIENTISTS EDUCATION IN UKRAINE: FOCUS ON NEUROSCIENCE Olena Kysil Palladin Institute of Biochemistry of the National Academy.
Genetic advances will only be acceptable if their application is carried out ethically, with due regard to autonomy, justice, education and the beliefs.
Responsible Stewardship: Choices and Challenges in Preventing the Malign Use of the Life Sciences Brian Rappert.
Biotechnology By Denise Ogden Using Biometrics in online learning systems.
Environmental and technology ethics Uncertainty, risk and precaution.
BSAF-BIONET Meeting Robert J. Hashimoto, CBSP University of California, Berkeley October 2, 2009.
Dual Use Research of Concern Boston University and Boston Medical Center.
Chapter 12 The Macro Environment – Technological Influences
Fostering a ‘Whole Community’ Approach to Emergency Management David J. Kaufman Director, Office of Policy and Program Analysis 8 June 2011.
Excellence in science The Royal Society is the independent scientific academy of the UK dedicated to promoting excellence in science. Royal Society’s work.
Safety organization and training. The biosafety officer and biosafety committee A safety policy, A safety manual, and Supporting programmes for their.
Dual Use Research of Concern (DURC) University of North Carolina at Greensboro.
SYNBIOLOGY - An Analysis of Synthetic Biology Research in Europe and North America 4,5/4,5 CM SYNBIOLOGY: An Analysis of Synthetic Biology Research in.
2. Network objectives RoSBNet brings together people working in Synthetic and Systems Biology as well as systems/ control, electrical, chemical and computer.
Information Ethics Prof. Madya Dr. Rozinah Jamaludin 11 March 2010.
High containment microbiology laboratories in Europe Ingegerd Kallings, Swedish Institute for Communicable Disease Control, Stockholm, Sweden and Kathrin.
1 EU Public Health Programme Work on Environment and Health Giulio Gallo Health & Consumer Protection Directorate Public Health and Risk Assessment Health.
World Health Organization Life science research: opportunities and risks for public health Ottorino Cosivi Department of Epidemic and Pandemic Alert and.
Non-O157 STEC: New Challenges / Practical Limitations / Next Steps Robert L. Buchanan HHS Food and Drug Administration Center for Food Safety and Applied.
ASCAC-BERAC Joint Panel on Accelerating Progress Toward GTL Goals Some concerns that were expressed by ASCAC members.
FLAGSHIP STRATEGY 1 STUDENT LEARNING. Student Learning: A New Approach Victorian Essential Learning Standards Curriculum Planning Guidelines Principles.
Synthetic biology and technology assessment A new generation? Go Yoshizawa Graduate School of Publicy Policy (GraSPP) University of Tokyo UK-Japan Seminar.
Genomes To Life Biology for 21 st Century A Joint Initiative of the Office of Advanced Scientific Computing Research and Office of Biological and Environmental.
European Public Health Alliance Lobbying, the role of NGOs and communication strategies Tamsin Rose Sofia, 29 October 2005.
The RDI Governance System Vasileios Pitsinigkos Head of Managing Authority of Eastern Macedonia - Thrace Region.
“What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.
Biotechnology By Denise Ogden Using Biometrics in online learning systems.
Health care responses to domestic violence: end of the beginning? Gene Feder Mental Health in the Context of Domestic Abuse Conference September 15 th.
Climate Change – Defra’s Strategy & Priorities Dr Steven Hill Department for Environment Food and Rural Affairs 22 nd May 2007 FLOODING DESTRUCTION AT.
“Participation is a Goal, not just a Means, in NFPs.” Margaret A. Shannon, Ph.D. COST Action E-19 Vienna, September 15, 2003.
By Annemarie van Paassen Knowledge Technology & Innovation group
Royal Irish Academy Briefing Bert Rima 109/01/2016.
AUSTRALIA. A National Strategy for Enhancing the Safety and Security of our Food Supply ที่มา : We pride ourselves on our high safety and security standards.
Richard Swetenham Head of Unit of eContent and Safer Internet European Commission, General Directorate Information Society and Media Safer Internet Programme:
Synthetic Biology and Biosecurity Brett Edwards Biochemical Security 2030 Project University of Bath SfAM Winter Meeting 15/0/14.
ERINHA: Framework for the biological high containment research infrastructure STOA – AVIESAN Workshop June 19th 2012, European Parliament, Brussels.
SPANISH NATIONAL POLICE INNOVATION & DEVELOPMENT SERVICE LOGISTICS GENERAL DIRECTORATE SMI2GS - H2020, BRUSSELS 26 & 27 February 2016 H2020 (CALL 2016)
Office of Special Projects Issues arising from the Second Review Conference on Safety and Security at Chemical Plants and Relationships with CWC stakeholders.
Dual-use Governance in Synthetic Biology Promises, Hype and Security Brett Edwards, University of Bath.
Preparing for the Title III Part F STEM Competition Alliance of Hispanic Serving Institutions Educators Grantsmanship Institute March 20, 2016.
Understanding Healthcare Provider and Decision-Maker Perspectives on Health Technology Reassessment: A Qualitative Research Study LESLEY J.J. SORIL, GAIL.
Synthetic Biology Market Global synthetic biology market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast.
Progress of the preparations for a White Paper on Adaptation to Climate Change Water Directors’ meeting Slovenia June 2008 Marieke van Nood, Unit.
Untangling cutting-edge biotech misuse concern
UN BWC Meeting of States Parties
Presentation transcript:

Synthetic Biology and Illegal Weapon Development Promises, Promises Brett Edwards

Overview -Synthetic Biology and misuse concern -Promises about Synthetic Biology and governance -Underperformance and narrowing of focus -The next steps: Re-invigoration or distraction?

Synthetic Biology (1) Defined initially by funding councils and research communities Promissory Interdisciplinary Controllable Biology Application of engineering Principles?

Synthetic Biology (2) Six subfields (Lam et al 2009) – DNA circuits standard biological parts – Synthetic metabolic pathways biological synthesis of chemicals – Proto-cell creation model of a cell – Unnatural components New proteins, with functions – Synthetic microbial consortia Cells, working together

Range of misuse concerns ScenarioExample Terrorist misuse Terrorist group use technologies and scientific knowledge to synthesis select-agent. Bad scientific practice A Scientist, through bad biosafety practice, allows dangerous pathogen to escape ‘home-made’ lab. Criminal misuse of technology The use of new techniques for the development of illegal drugs such as LSD. Prank/ Publicity stunt Student group release modified organism which cause harm or public panic. State level misuse Scientists directly/indirectly contribute to covert weapons programme. Inside JobRogue scientist in biodefense programme orchestrates attack.

Why So much Synthetic Biology Chatter? Synthetic Biologists National Security ELSI Community Gene Synthesis Industry Non-proliferation Bio-hackers

Early Anxieties Concerns about Gene- Synthesis technology 2003 US/ UK government and emerging US SB community Concerns integrated in to EU then UK funding Criteria for Synthetic Biology research networks Concerns integrated into US NSF funding Criteria for SynBERC - Concerns broadened to include: State, terrorist and amateur misuse Concerns prominent in ethics reports SB community and industry identified as central in forward looking responses

National focus of response Dual-use research – i.e identification of experiments of concern Dual-use Technology – I.e Industry screening of DNA sequences Dual-use techno-science – i.e changing innovation practices and relationship of fields with existing governance systems

Key Promises Action of a responsible scientific community in developing responses Eventual response by state – Significant driver of self-governance response, also added legitimacy Anticipatory responses to ensure safe development.

Policy developments and narrowing ( ) Risk assessment and policy response activities in the US and UK -Narrowed to focus on terrorism and Laboratory biosafety and biosecurity -Slow moving Federal Response US on both research and tech concerns -Stalled response from UK government

Main out come Over-reach – US and UK institutions better at articulating concerns than responding to them NSABB/ Community/ Ethics bodies Externalisation of long term trend and militarization concerns Government adopts scientists/ industry responsibility and biosafety framing.

Examples Forward looking concerns narrowed -Sloan report: -Problem definition ‘feed back’ -Industry outpaces government -Absence of support for screening- uncertainty over future of screening

Consequential myths Belief that issue has ‘already been dealt with’ within some aspects of the community Belief that there has been a separate government strand of policy development Belief that Industry and Scientific community can identify fully respond to early ethical concerns ( )

Possible Contradictions Low substantive knowledge within much of the scientific community Absence of international agreement on gene-synthesis industry Continued case by case focus Embryonic dual-use/ethics review in military investors Absence of risk assessment criteria. Struggles to implement ‘up-stream’ engagement – Synbio communities – Regulators

Outcome We are waiting for the next ‘big thing’. – Threat/ incident/ tech-advance

Positives Synthetic Biology has become a ‘test- case’ often referred to at international level Evidence of awareness raising outreach Expressed positions by key institutions to some aspects of the field

New project

Thanks! Brett Edwards